These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 7821301)

  • 1. Genetics of extended-spectrum beta-lactamases.
    Jacoby GA
    Eur J Clin Microbiol Infect Dis; 1994; 13 Suppl 1():S2-11. PubMed ID: 7821301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Origin and impact of plasmid-mediated extended-spectrum beta-lactamases.
    Philippon A; Arlet G; Lagrange PH
    Eur J Clin Microbiol Infect Dis; 1994; 13 Suppl 1():S17-29. PubMed ID: 7821300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S; Muniandy S; Navaratnam P
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's new in antibiotic resistance? Focus on beta-lactamases.
    Babic M; Hujer AM; Bonomo RA
    Drug Resist Updat; 2006 Jun; 9(3):142-56. PubMed ID: 16899402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to oxyimino beta-lactams due to a mutation of chromosomal beta-lactamase in Citrobacter freundii.
    Haruta S; Nukaga M; Taniguchi K; Sawai T
    Microbiol Immunol; 1998; 42(3):165-9. PubMed ID: 9570281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.
    Bradford PA
    Clin Microbiol Rev; 2001 Oct; 14(4):933-51, table of contents. PubMed ID: 11585791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamases.
    Giakkoupi P; Tzelepi E; Legakis NJ; Tzouvelekis LS
    J Antimicrob Chemother; 1999 Jan; 43(1):23-9. PubMed ID: 10381097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitution of Thr for Ala-237 in TEM-17, TEM-12 and TEM-26: alterations in beta-lactam resistance conferred on Escherichia coli.
    Giakkoupi P; Hujer AM; Miriagou V; Tzelepi E; Bonomo RA; Tzouvelekis LS
    FEMS Microbiol Lett; 2001 Jul; 201(1):37-40. PubMed ID: 11445164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Enterobacter cloacae from a Teaching Hospital in China.
    Liu G; Ling BD; Zeng Y; Lin L; Xie YE; Lei J
    Jpn J Infect Dis; 2008 Jul; 61(4):286-9. PubMed ID: 18653970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyimino-beta-lactams.
    Jacoby GA
    Infect Dis Clin North Am; 1997 Dec; 11(4):875-87. PubMed ID: 9421705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended-spectrum plasmid-mediated beta-lactamases.
    Sirot D
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():19-34. PubMed ID: 8543494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Appearance of extended-spectrum beta-lactamases].
    Iyobe S
    Nihon Rinsho; 1997 May; 55(5):1219-24. PubMed ID: 9155178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity and specificity of various beta-lactam antibiotics and phenotypical methods for detection of TEM, SHV and CTX-M extended-spectrum beta-lactamases.
    Bedenic B; Vranes J; Mihaljevic Lj; Tonkic M; Sviben M; Plecko V; Kalenic S
    J Chemother; 2007 Apr; 19(2):127-39. PubMed ID: 17434820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of a plasmid mediated AmpC-like beta-lactamase by a Klebsiella pneumoniae septicaemia isolate.
    Pörnull KJ; Rodrigo G; Dornbusch K
    J Antimicrob Chemother; 1994 Dec; 34(6):943-54. PubMed ID: 7730237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective study of an outbreak in a Kuwaiti hospital of multidrug-resistant Klebsiella pneumoniae possessing the new SHV-112 extended-spectrum beta-lactamase.
    Dashti AA; Jadaon MM; Amyes SG
    J Chemother; 2010 Oct; 22(5):335-8. PubMed ID: 21123157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Beta-lactamases in laboratory and their role in resistance Part I.: Evolution of bacterial resistance mediated by beta-lactamases].
    Bedenić B
    Lijec Vjesn; 2004; 126(11-12):314-24. PubMed ID: 16082890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Extended spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae].
    Bedenić B
    Lijec Vjesn; 1996 Oct; 118(10):244-8. PubMed ID: 9132524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SHV-type beta-lactamases.
    Tzouvelekis LS; Bonomo RA
    Curr Pharm Des; 1999 Nov; 5(11):847-64. PubMed ID: 10539992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in beta-lactam resistance among Enterobacteriaceae.
    Nordmann P
    Clin Infect Dis; 1998 Aug; 27 Suppl 1():S100-6. PubMed ID: 9710678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.